Investment Research Radio okładka

Investment Research Radio

Investment Research Radio

Autor: Investment Research Radio
Słuchaj bezpłatnie, bez subskrypcji

Das größte Angebot der Saison | 0,99 € pro Monat für die ersten 3 Monate + 15 € Audible-Guthaben

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.
O tym tytule
Investment Research Radio interviews the most exciting up and coming companies trading on the markets. Leading business minds, analysts and market commentators are also interviewed-. While being sector agnostic there is a focus on clean technologies, blockchain and being on top of the major trends which are changing the world around us. Ekonomia Finanse osobiste Polityka i rządy
  • Emet Surgical With CEO Bob Witkow
    Nov 18 2026
    Bob Witkow, Founder & CEO of Emet Surgical: Bringing AI-Powered Intelligence Into the Operating Room

    In this episode of Investment Research Radio, I sit down with Bob Witkow, Founder and CEO of Emet Surgical, a medical technology company developing AI powered surgical guidance to improve precision and decision making during minimally invasive procedures.

    Emet Surgical is developing its Enhanced Surgical Precision (ESP) system, software designed to analyze surgical video in real time, identify potential abnormalities and provide visual guidance to surgeons directly within the operating room. Its initial applications include incidental cancer detection during routine procedures, with further development focused on identifying endometriosis lesions that can be difficult to detect.

    Bob's journey to founding Emet Surgical is deeply personal. Following his own experience with cancer, multiple surgeries and complications, he became focused on addressing gaps in the information available to surgeons during procedures and reducing the likelihood of missed pathology and repeat operations.

    Our conversation explores:

    • Bob's entrepreneurial and technology background and the personal experience that led him to establish Emet Surgical.

    • The limitations of visualization and decision making in minimally invasive surgery.

    • How ESP uses artificial intelligence and computer vision to provide real time surgical insights.

    • The potential applications in cancer detection and endometriosis surgery.

    • The company's licensed intellectual property from the University of Minnesota and the research behind the technology.

    • Clinical validation, the FDA 510(k) regulatory pathway and commercialization strategy.

    • Opportunities for integration and strategic partnerships with established surgical equipment and technology companies.

    • The broader future of AI assisted surgery and how data driven insights could improve patient care.

    Emet Surgical is working to make critical information more visible to surgeons when decisions matter most. Bob brings a unique combination of technology entrepreneurship and personal patient experience to a significant challenge in modern surgical care.

    Learn more about Emet Surgical:
    https://emetsurgical.com/

    Guest: Bob Witkow, Founder & CEO, Emet Surgical

    Host: Ray Crowley, Investment Research Radio

    Investment Research Radio features conversations with founders, executives, investors and innovators advancing emerging technologies and building businesses across the global economy both private and publicly listed ventures.

    Rozwiń Zwiń
    16 min
  • Pretika MedTech With CEO Thomas Nichols
    Nov 16 2026
    Thomas Nichols, CEO of Pretika MedTech: Transforming Wound Care Through Connected Medical Devices, Imaging and AI

    In this episode of Investment Research Radio, host Ray Crowley speaks with Thomas Nichols, Founder and CEO of Pretika MedTech, about the company's vision for transforming wound care through connected medical devices, embedded imaging, sensor technology and digital health intelligence.

    Thomas discusses Pretika's Connected Wound Care technology and its flagship OptixDX system, designed to integrate advanced imaging and sensing capabilities into wound dressings, enabling clinicians to monitor healing and identify potential complications without removing dressings or disturbing the wound.

    The conversation explores the limitations of traditional wound management, the potential of multispectral and hyperspectral imaging, remote patient monitoring, AI-driven analytics and the development of connected medical technologies that could improve post-surgical recovery and chronic wound management.

    We also discuss medical device innovation, clinical validation, FDA regulatory pathways, commercialization strategy and the broader opportunity to modernize wound care across hospitals and outpatient settings.

    Investment Research Radio
    Hosted by Ray Crowley

    https://pretikamedtech.com/

    Rozwiń Zwiń
    17 min
  • BiRed Imaging with Dr. Satish Kandlikar CEO and Dr. Prad Phatak CMO
    Nov 13 2026
    BiRed Imaging: Exploring a New Approach to Breast Cancer Detection Through Infrared Imaging and AI

    What if infrared imaging and artificial intelligence could offer clinicians a new source of information to support breast cancer detection and assessment?

    On this episode of Investment Research Radio, we speak with Professor Satish Kandlikar, CEO and Co founder of BiRed Imaging, and Dr. Pradyumna ("Prad") Phatak, Chief Medical Officer, about the development of an innovative approach to breast cancer detection combining infrared imaging, mathematical modeling and artificial intelligence.

    BiRed Imaging is developing a noninvasive imaging technology designed to identify and localize potential breast tumors by analyzing the body's natural thermal signatures. The system combines infrared camera measurements with patient specific digital breast models and numerical heat transfer simulations to help assess the presence, size and location of potential abnormalities.

    The technology offers an exciting avenue of research with the potential to complement existing breast imaging approaches and provide additional diagnostic information. Its noninvasive nature, lack of radiation exposure and potential application for women with dense breast tissue make it an interesting area of emerging medical technology.

    In this conversation, we explore:

    • The origins of BiRed Imaging and the research that inspired its development.

    • How infrared imaging and mathematical modeling can identify thermal patterns potentially associated with breast tumors.

    • How the technology aims to determine the potential size and location of tumors.

    • The limitations and challenges of current breast cancer screening approaches and the opportunity for complementary technologies.

    • Early research findings and the importance of continued clinical validation.

    • The potential application of the technology for women with dense breast tissue.

    • The role of artificial intelligence and computational modeling in advancing breast imaging.

    • Regulatory considerations, clinical studies and the pathway toward commercialization.

    • The broader opportunity to make breast cancer screening more accessible, comfortable and informative.

    Professor Kandlikar brings extensive engineering and research experience to the development of the technology, while Dr. Phatak contributes important clinical and medical perspectives on breast cancer detection and patient care.

    BiRed Imaging is pursuing a promising approach that could contribute to the future of breast imaging by providing clinicians with another tool to investigate and assess potential abnormalities. While further research and clinical validation will be important in establishing its capabilities, the technology represents an exciting opportunity to explore new possibilities in breast cancer detection.

    Learn more about BiRed Imaging:

    https://www.biredimaging.com/

    Thank you to Professor Satish Kandlikar and Dr. Pradyumna Phatak for joining Investment Research Radio.

    Rozwiń Zwiń
    19 min
adbl_web_anon_alc_button_suppression_t1
Brak recenzji